ADA and severe combined immunodeficiency: It is usedto treat severe combined immunodeficiency disease (SCID) caused bya deficiency in adenosine deaminase (ADA).21 Native ADA has a circulation half-life of 30 min in mice after intravenous(i.v.) injection.